Nestle, Zydus, Abbott face India scrutiny over claims on children's products
The regulator asked the companies to justify health and growth claims on infant and children’s products or face action under advertising rules.
- On Wednesday, the Food Safety and Standards Authority of India issued notices to Nestle India, Zydus Wellness, and Abbott Healthcare over promotional claims on infant and children's products that allegedly breach regulations.
- This action follows recent proposals to ban added sucrose and fructose in infant foods, as India scrutinizes the $100 billion packaged food industry to enforce stricter safety and labeling standards.
- Regulators questioned Complan's '2X Faster Growth' claim and NAN Excella Pro Stage's assertion that '5 HMOs helps support normal immune system ', citing non-compliance with permitted claims.
- The authority directed companies to provide scientific justification for these claims and show cause why action should not be taken within a stipulated period, the regulator said.
- Separately, the FSSAI is scrutinizing alleged promotional activities by influencers on Instagram, expanding oversight beyond traditional advertising to ensure compliance with FSS regulations regarding advertising and claims.
15 Articles
15 Articles
FSSAI issues notices to Nestle, Zydus Wellness over ‘misleading claims’ in Complan, Lactogen, Nan
The Food Safety and Standards Authority of India has issued notices regarding misleading claims by Nestle and Zydus Wellness. Nestle's Lactogen Pro 1 Powder and Nan Excella Pro Stage 1 have claims needing scientific support. Zydus Wellness received scrutiny for Complan claims relating to growth and memory. Companies have been directed to justify their assertions and face possible action.
FSSAI Issues Notices to Major Food Manufacturers, Others over Misleading Claims on Infant Nutrition Products
Get latest articles and stories on Business at LatestLY. The Food Safety and Standards Authority of India (FSSAI) has issued fresh notices to major food manufacturers and other entities over alleged misleading health claims and non-compliant promotions involving infant nutrition products, including claims related to immunity and digestion. Business News | FSSAI Issues Notices to Major Food Manufacturers, Others over Misleading Claims on Infant N…
Nestle, Zydus, Abbott face India scrutiny over claims on children's products
India's food safety regulator issued notices to Nestle India , Zydus Wellness , Abbott Healthcare and others on Wednesday over promotional claims involving products for infants and children that it said breached rules.
FSSAI seeks proof from Nestle, Abbott and Zydus over infant formula, Complan ad claims
FSSAI has issued notices to Nestle India, Abbott Healthcare and others over infant formula claims and alleged illegal promotions on social media. It has also sought scientific evidence from Zydus Wellness to substantiate Complan's growth, immunity and cognitive benefit claims.
Coverage Details
Bias Distribution
- 60% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
